Merck Closes Down Its Propecia Website
Wednesday, February 15th, 2012The Propecia webpage owned by Merck Pharmaceuticals provided links to current prescribing information, patient product information, and a link encouraging visitors to report any adverse effects associated with use of Propecia to the FDA’s MedWatch program.
Merck has abruptly shut down this website, which has prompted speculation that new or additional warnings may be on their way to consumers regarding the sexual side effects that have been reported with the use of Propecia.
Several lawsuits have been filed against Merck Pharmaceuticals, manufacturer of Propecia,
Propecia is used to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland) and baldness. The lawsuits accuse Merck of downplaying the risks associated with Propecia and failing to warn patients about the severity of sexual side effects.
The side effects that have plagued men are: decreased libido, decreased semen output, and depression. Because so many men feel embarrassment about the side effects of Propecia, scores have chosen to remain anonymous or to not report their conditions. In June 2011, the FDA issued a warning that Propecia could be linked to an increased risk of high-grade prostate cancer.